Canada Markets close in 3 mins

Lattice Biologics Ltd. (LBL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0350+0.0050 (+16.67%)
As of 1:56PM EDT. Market open.
Currency in CAD

Valuation Measures

Market Cap (intraday) 54.49M
Enterprise Value 36.84M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.05
Price/Book (mrq)N/A
Enterprise Value/Revenue 33.12
Enterprise Value/EBITDA 6-9.16

Trading Information

Stock Price History

Beta (5Y Monthly) -13.58
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.2100
52 Week Low 30.0200
50-Day Moving Average 30.0373
200-Day Moving Average 30.0583

Share Statistics

Avg Vol (3 month) 3158.77k
Avg Vol (10 day) 3105.88k
Shares Outstanding 5128.22M
Float 44.06M
% Held by Insiders 113.67%
% Held by Institutions 10.00%
Shares Short (Oct. 14, 2020) 4392.66k
Short Ratio (Oct. 14, 2020) 43.19
Short % of Float (Oct. 14, 2020) 4N/A
Short % of Shares Outstanding (Oct. 14, 2020) 40.31%
Shares Short (prior month Aug. 30, 2020) 4115k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:3
Last Split Date 3Jan. 03, 2016

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Sep. 29, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin -87.24%
Operating Margin (ttm)-42.44%

Management Effectiveness

Return on Assets (ttm)-21.50%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.19M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)12.60%
Gross Profit (ttm)997.51k
EBITDA -746.47k
Net Income Avi to Common (ttm)-1.91M
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.65k
Total Cash Per Share (mrq)0
Total Debt (mrq)3.01M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.13
Book Value Per Share (mrq)-0.06

Cash Flow Statement

Operating Cash Flow (ttm)-2.46k
Levered Free Cash Flow (ttm)-221.73k